| 英文名称 |
中文名称 |
CAS |
|
Ammelide
|
三聚氰胺一酰胺 |
645-93-2 |
|
Ledipasvir intermediate
|
雷迪帕韦中间体 |
1256387-87-7 |
|
Daclatasvir
|
达卡他韦 |
1009119-64-5 |
|
Velpatasvir API
|
维帕他韦 |
1377049-84-7 |
|
Velpatasvir intermediate
|
维帕他韦中间体 |
1378390-29-4 |
|
Daclatasvir intermediate
|
达卡他韦中间体 |
24860-53-5 |
|
Ledipasvir intermediate
|
雷迪帕韦中间体 |
1256388-50-7 |
|
Velpatasvir intermediate
|
维帕他韦中间体 |
1378391-45-7 |
|
Velpatasvir intermediate;tert-butyl (2S,4S)-2-[5-(2-{(2S,5S)-1-[N-(methoxycarbonyl)-L-valyl]-5-methylpyrrolidin-2-yl}-1,4,5,11-tetrahydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-9-yl)-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate;Velpatasvir intermediate N-3;intermediate of Velpatasvir
|
|
1378391-44-6 |
|
(2S)-4-Oxo-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester
|
(2S)-4-氧代-2-(3-噻唑烷基羰基)-1-吡咯烷羧酸叔丁酯 |
401564-36-1 |
|
[5-Bromo-3-[(1R)-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-2-yl]amine
|
[5-溴-3-[(1R)-(2,6-二氯-3-氟苯基)乙氧基]吡啶-2-基]胺 |
877399-00-3 |
|
Crizotinib intermediate
|
4-[4-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)-1H-吡唑-1-基]哌啶-1-甲酸叔丁酯 |
877399-74-1 |
|
Gatifloxacin API
|
|
112811-59-3 |
|
Lubiprostone API
|
鲁比前列酮 |
136790-76-6 |
|
Lurasidone Hydrochloride API
|
盐酸鲁拉西酮 |
367514-88-3 |
|
Trelagliptin Succinate API
|
曲格列汀琥珀酸盐 |
1029877-94-8 |
|
Vilazodone hydrochloride API
|
盐酸维拉佐酮 |
163521-08-2 |
|
Ledipasvir API
|
雷迪帕韦单丙酮溶剂合物 |
1441674-54-9 |
|
Ledipasvir solid dispersion in copovidone
|
雷迪帕韦固体分散体 |
|
|
Voxilaprevir intermediate;GS9857
|
GS9857中间体 |
1799733-54-2 |
|
Velpatasvir solid dispersion with copovidone
|
维帕他韦固体分散体 |
|
|
Daclatasvir API
|
达卡他韦二盐酸盐 |
1009119-65-6 |
|
Treprostinil
|
曲前列尼尔 |
81846-19-7 |
|
Treprostinil Sodium API
|
曲前列尼尔钠 |
289480-64-4 |
|
Bimatoprost API
|
贝美前列素 |
155206-00-1 |
|
Latanoprost API
|
拉坦前列素 |
130209-82-4 |
|
L-Valine, 3-Methyl-N-[[[(1R,2R)-2-(4-penten-1-yl)cyclopropyl]oxy]carbonyl]-
|
Grazoprevir 中间体 |
1026200-27-0 |
|
(1R,2R)-1-amino-2-(difluoromethyl)-N-(1-methylcyclopropylsulfonyl) cyclopropanecarboxamide hydrochloride
|
|
1360828-80-3 |
